Susquehanna International Group
TENX icon

Susquehanna International Group’s Tenax Therapeutics TENX Stock Holding History

Susquehanna International Group’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1
Closed -$43K – 9041
2016
Q2 		$43K Buy
+1
New +$83.4K ﹤0.01% 8273
2014
Q3 		– Sell
-4
Closed -$543K – 9944
2014
Q2 		$543K Buy
+4
New +$617K ﹤0.01% 7307

Other funds holding TENX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Susquehanna International Group's TENX Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Tenax Therapeutics (TENX) in Q1 2026: 28,977 shares worth $463K. The stake represents ﹤0.01% of the portfolio and ranks #9873 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in TENX as recently as Q4 2023.

Susquehanna International Group first reported a position in TENX in Q1 2014 and has held it in 6 quarters since. The position peaked at $666K in Q2 2014. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

  • Susquehanna International Group held 28,977 shares of Tenax Therapeutics worth $463K as of Q1 2026.
  • Tenax Therapeutics was a new Susquehanna International Group position in Q1 2026.
  • Tenax Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9873 holding.
  • Susquehanna International Group first reported a position in Tenax Therapeutics in Q1 2014 and has held it in 6 quarters since.
  • Susquehanna International Group's Tenax Therapeutics position peaked at $666K in Q2 2014.
  • 80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.